US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

S-Benzalkonium Chloride 0.013% Solution

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0205-2020
Class II · Moderate risk Terminated

S-B5/B6/B12m 100/50/10mg/Ml Mdv Soln

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0204-2020
Class II · Moderate risk Terminated

S-Atropine 0.5% Opth Soln

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0203-2020
Class II · Moderate risk Terminated

S-Atropine 0.02% Opthalmic Solution

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0202-2020
Class II · Moderate risk Terminated

S-Atropine 0.01% Ophthalmic Solution

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0201-2020
Class II · Moderate risk Terminated

S-Ascorbic Acid 500mg/Ml Mdv Soln

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0199-2020
Class II · Moderate risk Terminated

S-Amitriptyline 10mg/Ml Mdv Inj Soln

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0198-2020
Class II · Moderate risk Terminated

Soothing Sore Relief

Reason Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Ridge Properties, LLC NDC 69804-077-14 D-1861-2019
Class II · Moderate risk Terminated

Soothing Sore Relief

Reason Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Ridge Properties, LLC NDC 69804-074-05 D-1860-2019
Class II · Moderate risk Terminated

Superior Pain & Itch Relief

Reason Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Ridge Properties, LLC NDC 69804-073-14 D-1859-2019
Class II · Moderate risk Terminated

Superior Pain & Itch Relief

Reason Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Ridge Properties, LLC NDC 69804-070-05 D-1858-2019
Class II · Moderate risk Terminated

Pre-Tat

Reason Microbial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.

Ridge Properties, LLC NDC 69804-019-14 D-1857-2019
Class II · Moderate risk Terminated

Pre-Tat

Reason Microbial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.

Ridge Properties, LLC NDC 69804-002-05 D-1856-2019
Class II · Moderate risk Terminated

Carbamazepine

Reason Failed Dissolution Specifications

American Health Packaging D-1821-2019
Class II · Moderate risk Terminated

Vivitrol

Reason Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.

Alkermes Inc D-1846-2019
Class III · Low risk Terminated

Eptifibatide Injection

Reason Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.

Akorn, Inc. NDC 17478-902-10 D-1841-2019
Class III · Low risk Terminated

Eptifibatide Injection

Reason Short Fill: fill volume was out of specification at 94 mL (specification: no less than 100 mL) and Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.

Akorn, Inc. NDC 17478-903-90 D-1840-2019
Class III · Low risk Terminated

Eptifibatide Injection

Reason Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.

Akorn, Inc. NDC 17478-903-90 D-1839-2019
Class II · Moderate risk Terminated

Lisinopril/HCTZ 20mg/12.5mg Tablet

Reason Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.

RemedyRepack Inc. NDC 68180-0519-02 D-1030-2020
Class III · Low risk Terminated

Simvastatin Tablets

Reason Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B

Aurobindo Pharma USA Inc. NDC 65862-053-99 D-1842-2019
Class II · Moderate risk Terminated

Bexarotene Capsules

Reason Failed Dissolution Specifications

Upsher Smith Laboratories, Inc. D-1836-2019
Class II · Moderate risk Terminated

Clear Eyes Redness Relief Hand Pocket Pal Tray Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1835-2019
Class II · Moderate risk Terminated

Clear eyes REDNESS RELIEF

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1834-2019